Categories Earnings, Health Care

BMY Earnings: A snapshot of Bristol-Myers Squibb’s Q2 2023 results

Biotechnology company Bristol Myers Squibb (NYSE: BMY) on Thursday said its second-quarter adjusted earnings decreased year-over-year, hurt by a fall in revenues.

Bristol-Myers Squibb Company Q2 2023 earnings infographic

Net income attributable to shareholders was $2.07 billion or $0.99 per share in the June quarter, compared to $1.42 billion or $0.66 per share in the comparable period of 2022. Adjusted profit, meanwhile, declined to $1.75 per share in Q2 from $1.93 per share in the prior-year period.

Second-quarter revenues decreased 6% from last year to $11.23 billion. Domestic revenues declined by 5%, and international revenues dropped by 8%.

Prior Performance

  • Bristol Myers Squibb Q4 2022 earnings infographic
  • Bristol-Myers-Squibb-Q3-2022-Earnings-Infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Key highlights from Carnival Corporation’s (CCL) Q3 2023 earnings results

Carnival Corporation & plc (NYSE: CCL) reported third quarter 2023 earnings results today. Revenues were $6.9 billion compared to $4.3 billion in the same period last year. On a GAAP basis,

NKE Earnings: Here’s everything you need to know about Nike’s Q1 report

Nike, Inc. (NYSE: NKE) on Thursday reported results for the first three months of fiscal 2024, reporting a modest rise in revenues. The sneaker giant reported net income of $1.45

Key takeaways from Accenture’s (ACN) Q4 2023 earnings report

Shares of Accenture plc (NYSE: ACN) were down 4% on Thursday after the company delivered mixed results for the fourth quarter of 2023 and provided full-year guidance that came below

Add Comment
Viewing Highlight